US equities
|
MU
$989.04
▼-3.88%
META
$742.96
▲+3.38%
NVDA
$226.32
▼-1.29%
SNDK
$1,487.33
▼-5.97%
SPCX
$163.42
▲+0.52%
MSFT
$541.15
▲+1.14%
AMD
$594.24
▼-2.28%
AAPL
$340.97
▲+1.29%
MU
$989.04
▼-3.88%
META
$742.96
▲+3.38%
NVDA
$226.32
▼-1.29%
SNDK
$1,487.33
▼-5.97%
SPCX
$163.42
▲+0.52%
MSFT
$541.15
▲+1.14%
AMD
$594.24
▼-2.28%
AAPL
$340.97
▲+1.29%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Bausch + Lomb
Bausch + Lomb Announces Phase 2 Results for Glaucoma Neuroprotective Candidate
July 09, 2026
From
Bausch + Lomb
Via
Business Wire
Tickers
BLCO
TSX:BLCO
Bausch + Lomb Introduces Orphia™, an AI-Powered Digital Health Platform Built to Return Physicians to Patient Care
July 09, 2026
From
Bausch + Lomb
Via
Business Wire
Tickers
BLCO
TSX:BLCO
Bausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Optometry Annual Meeting
October 04, 2023
From
Bausch + Lomb
Via
Business Wire
Tickers
BLCO
TSX:BLCO
Bausch + Lomb and Heidelberg Engineering Announce the Introduction of SeeLuma™ Fully Digital Surgical Visualization Platform
April 13, 2023
From
Bausch + Lomb
Via
Business Wire
Tickers
BLCO
TSX:BLCO